Fredun Pharmaceuticals Delivers Stellar Q1 FY27 Performance; Revenue Jumps 90%, EBITDA Surges 93% and Profit Rises 95% YoY

Mumbai (Maharashtra) [India], August 6: Fredun Pharmaceuticals Limited (BSE: FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Q1 FY27 Standalone Financial Highlights Total Income of ₹228.25 Cr, YoY […]

Continue Reading

Fredun Pharmaceuticals Expands Manufacturing Base with Fifth Facility at Palghar

Mumbai (Maharashtra) [India], April 29: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies with a diversified presence across generics, cosmeceuticals, nutraceuticals, mobility, and animal healthcare products, has announced the establishment of a new manufacturing facility in Palghar, Maharashtra, marking the addition of its fifth facility. Manufacturing Expansion […]

Continue Reading
Infomerics Upgrade Fredun Pharmaceuticals Credit Rating to BBB Plus; Boosts Financial Profile-PNN

Infomerics Upgrade Fredun Pharmaceuticals Credit Rating to BBB Plus; Boosts Financial Profile

Mumbai (Maharashtra) [India], February 26: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility, and animal healthcare products, has secured a credit rating upgrade from Infomerics Valuation and Rating Limited for its bank facilities aggregating to ₹156.17 crore. Infomerics has […]

Continue Reading